UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region

The American journal of tropical medicine and hygiene, 2001-11, Vol.65 (5), p.405-413

2001

Volltextzugriff (PDF)

Efficacy Of A Quadrivalent Rhesus Rotavirus-Based Human Rotavirus Vaccine Aimed At Preventing Severe Rotavirus Diarrhea In Infants And Young Children

The Journal of infectious diseases, 1996-09, Vol.174 (Supplement-1), p.S65-S72

1996

Volltextzugriff (PDF)

A Large Array of Human Monoclonal Antibodies to Type 1 Human Immunodeficiency Virus from Combinatorial Libraries of Asymptomatic Seropositive Individuals

Proceedings of the National Academy of Sciences - PNAS, 1991-11, Vol.88 (22), p.10134-10137

1991

Volltextzugriff (PDF)

Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys

Journal of Virology, 1996-06, Vol.70 (6), p.3930-3937

1996

Volltextzugriff (PDF)

A Mouse Model for Investigating the Molecular Pathogenesis of Adenovirus Pneumonia

Proceedings of the National Academy of Sciences - PNAS, 1991-03, Vol.88 (5), p.1651-1655

1991

Volltextzugriff (PDF)

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults

Vaccine, 2000-03, Vol.18 (17), p.1763-1772

2000

Volltextzugriff (PDF)

Role of Early Region 3 (E3) in Pathogenesis of Adenovirus Disease

Proceedings of the National Academy of Sciences - PNAS, 1989-05, Vol.86 (10), p.3823-3827

1989

Volltextzugriff (PDF)

Human Monoclonal Fab Fragments Derived from a Combinatorial Library Bind to Respiratory Syncytial Virus F Glycoprotein and Neutralize Infectivity

Proceedings of the National Academy of Sciences - PNAS, 1992-11, Vol.89 (21), p.10164-10168

1992

Volltextzugriff (PDF)

Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus)

Journal of Virology, 1993-01, Vol.67 (1), p.101-111

1993

Volltextzugriff (PDF)

Antigenic Relationships Among Human Rotaviruses as Determined by Outer Capsid Protein VP4

Proceedings of the National Academy of Sciences - PNAS, 1990-09, Vol.87 (18), p.7155-7159

1990

Volltextzugriff (PDF)

Evaluation of a Live, Cold-Passaged, Temperature-Sensitive, Respiratory Syncytial Virus Vaccine Candidate in Infancy

The Journal of infectious diseases, 2000-11, Vol.182 (5), p.1331-1342

2000

Volltextzugriff (PDF)

Reappraisal of the Association of Intussusception with the Licensed Live Rotavirus Vaccine Challenges Initial Conclusions

The Journal of infectious diseases, 2003-04, Vol.187 (8), p.1301-1308

2003

Volltextzugriff (PDF)

Production of Infectious Human Respiratory Syncytial Virus from Cloned cDNA Confirms an Essential Role for the Transcription Elongation Factor from the 5' Proximal Open Reading Frame of the M2 mRNA in Gene Expression and Provides a Capability for Vaccine Development

Proceedings of the National Academy of Sciences - PNAS, 1995-12, Vol.92 (25), p.11563-11567

1995

Volltextzugriff (PDF)

A Hexavalent Human Rotavirus-Bovine Rotavirus (UK) Reassortant Vaccine Designed for Use in Developing Countries and Delivered in a Schedule with the Potential to Eliminate the Risk of Intussusception

The Journal of infectious diseases, 2005-09, Vol.192 (Supplement-1), p.S22-S29

2005

Volltextzugriff (PDF)

Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics

Advances in virus research, 1999, Vol.54, p.423

1999

Volltextzugriff (PDF)

Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus

Virology (New York, N.Y.), 2003-09, Vol.314 (1), p.190-195

2003

Volltextzugriff (PDF)

Recombinant Human Respiratory Syncytial Virus (RSV) Monoclonal Antibody Fab is Effective Therapeutically when Introduced Directly into the Lungs of RSV-Infected Mice

Proceedings of the National Academy of Sciences - PNAS, 1994-02, Vol.91 (4), p.1386-1390

1994

Volltextzugriff (PDF)

Live Subgroup B Respiratory Syncytial Virus Vaccines that Are Attenuated, Genetically Stable, and Immunogenic in Rodents and Nonhuman Primates

The Journal of infectious diseases, 1996-04, Vol.173 (4), p.829-839

1996

Volltextzugriff (PDF)

Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization

Pediatrics (Evanston), 1992-07, Vol.90 (1 Pt 2), p.137-143

1992

Volltextzugriff (PDF)

Independent Segregation of Two Antigenic Specificities (VP3 and VP7) Involved in Neutralization of Rotavirus Infectivity

Proceedings of the National Academy of Sciences - PNAS, 1985-12, Vol.82 (24), p.8701-8704

1985

Volltextzugriff (PDF)

Expression of the F Glycoprotein of Respiratory Syncytial Virus by a Recombinant Vaccinia Virus: Comparison of the Individual Contributions of the F and G Glycoproteins to Host Immunity

Proceedings of the National Academy of Sciences - PNAS, 1986-10, Vol.83 (19), p.7462-7466

1986

Volltextzugriff (PDF)

Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen

Journal of Virology, 1988-03, Vol.62 (3), p.744-748

1988

Volltextzugriff (PDF)

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

Journal of Virology, 1985-09, Vol.55 (3), p.517-520

1985

Volltextzugriff (PDF)

Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization

Vaccine, 1995-06, Vol.13 (9), p.847-855

1995

Volltextzugriff (PDF)

Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine

Journal of Clinical Microbiology, 1986-08, Vol.24 (2), p.197-202

1986

Volltextzugriff (PDF)

1 – 25 von 1.128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.071)
Mit Volltextzugriff
(899)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(887)
EZB Electronic Journals Library
(849)
Publisher website
(546)
Journals@Ovid Full Text
(428)
Ingenta
(380)
Oxford Journals
(219)
Oxford Journals 2020 Medicine
(214)
Jstor Complete Legacy
(136)
Elsevier ScienceDirect Journals Complete
(128)
Nature
(111)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(107)
Wiley Online Library
(90)
Nexis Uni
(87)
IngentaConnect Journals
(84)
Wiley Online Library Full Collection 2018
(56)
Springer Journals
(56)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(35)
SAGE Journals
(32)
EBSCOhost Psychology and Behavioral Sciences Collection
(17)
Science Magazine
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region

Efficacy Of A Quadrivalent Rhesus Rotavirus-Based Human Rotavirus Vaccine Aimed At Preventing Severe Rotavirus Diarrhea In Infants And Young Children

A Large Array of Human Monoclonal Antibodies to Type 1 Human Immunodeficiency Virus from Combinatorial Libraries of Asymptomatic Seropositive Individuals

Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys

A Mouse Model for Investigating the Molecular Pathogenesis of Adenovirus Pneumonia

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults

Role of Early Region 3 (E3) in Pathogenesis of Adenovirus Disease

Human Monoclonal Fab Fragments Derived from a Combinatorial Library Bind to Respiratory Syncytial Virus F Glycoprotein and Neutralize Infectivity

Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus)

Antigenic Relationships Among Human Rotaviruses as Determined by Outer Capsid Protein VP4

Evaluation of a Live, Cold-Passaged, Temperature-Sensitive, Respiratory Syncytial Virus Vaccine Candidate in Infancy

Reappraisal of the Association of Intussusception with the Licensed Live Rotavirus Vaccine Challenges Initial Conclusions

Production of Infectious Human Respiratory Syncytial Virus from Cloned cDNA Confirms an Essential Role for the Transcription Elongation Factor from the 5' Proximal Open Reading Frame of the M2 mRNA in Gene Expression and Provides a Capability for Vaccine Development

A Hexavalent Human Rotavirus-Bovine Rotavirus (UK) Reassortant Vaccine Designed for Use in Developing Countries and Delivered in a Schedule with the Potential to Eliminate the Risk of Intussusception

Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics

Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus

Recombinant Human Respiratory Syncytial Virus (RSV) Monoclonal Antibody Fab is Effective Therapeutically when Introduced Directly into the Lungs of RSV-Infected Mice

Live Subgroup B Respiratory Syncytial Virus Vaccines that Are Attenuated, Genetically Stable, and Immunogenic in Rodents and Nonhuman Primates

Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization

Independent Segregation of Two Antigenic Specificities (VP3 and VP7) Involved in Neutralization of Rotavirus Infectivity

Expression of the F Glycoprotein of Respiratory Syncytial Virus by a Recombinant Vaccinia Virus: Comparison of the Individual Contributions of the F and G Glycoproteins to Host Immunity

Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization

Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine

Suchergebnisse filtern